| NCT06463418 | Exoskeleton Training for Spinal Cord Injury Neuropathic Pain (ExSCIP) | University College Dublin | | - Age 18 - 65 yrs
- Level C1-S5
AIS - ≥ 6 months
| Recruiting | 40 | NA | | Pain | - International Spinal Cord Injury Pain Classification (ISCIP)
- Neuropathoc Pain Symptom Inventory (NPSI)
| 6 months | 20 December 2024 | 17 June 2024 | 1 | |
| NCT06464744 | Efficacy of rTMS Treatment After Spinal Cord Injury | Oslo University Hospital | | - Age 18 - 80 yrs
- Level C4-T12
AIS C, D- All
- NOT have implanted devices such as cardiac pacemaker and neurostimulator and cochlear implants
- NOT have an active cerebral tumor
- NOT have a history of epilepsy or ongoing epilepsy
- NOT have a history of treatment with Deep Brain Stimulation (DBS)
| Recruiting | 20 | NA | Technology | Standing/walking/mobility | - 10 Meter Walking Test (10 MWT)
- Ashworth and Modified Ashworth Scale (MAS)
- Motor Evoked Potentials (MEPs)
- Pain Numeric Rating Scale (NRS)
- Pendulum Test (Wartenberg)
| 12 weeks | 15 January 2024 | 18 June 2024 | 1 | |
| NCT06268093 | The Therapeutic Effect of Thalidomide in Syringomyelia | Xuanwu Hospital, Beijing | Single Group Assignment | - Age 18 - 80 yrs
- Level C1-S5
AIS - All
- NOT have a history of psychiatric diseases or seizures
- NOT have transplanted organs
- HAVE had surgical treatment of syringomyelia that was ineffective, or
- HAVE syringomyelia and have contraindications to surgical treatment
| Recruiting | 30 | Phase 2 | Drug | General health | - Adverse Events (AEs)
- American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Pain Visual Analog Scale (VAS)
- Surface Electromyography (sEMG)
| 3 months | 01 February 2024 | 20 February 2024 | 1 | |
| NCT06169969 | Effect Of Magnetic Therapy In Bladder Dysfunction And Quality Of Life In Paraplegic Patients | Cairo University | | - Age 20 - 35 yrs
- Level T6-T12
AIS A, B- ≥ 1 years
- NOT have a history of autonomic dysreflexia
- NOT have previous exposure to and use of spinal cord stimulation
- NOT have a history of bladder Botox injection or bladder/sphincter surgeries
| Ended | 40 | NA | Technology | Bladder health/function | - Needle electromyography
- Qualiveen
- Urodynamic examination
| 16 weeks | 05 November 2023 | 14 December 2023 | 1 | |
| NCT06242873 | Transcutaneous Spinal Cord Stimulation in Children With Incomplete Spinal Cord Injury | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | | - Age 3 - 16 yrs
- Level C1-T9
AIS C, D- ≥ 6 months
- NOT have a cardiac pacemaker or defibrillator
| Recruiting | 20 | NA | Technology | Standing/walking/mobility | - 10 Meter Walking Test (10 MWT)
- 6-Minute Walk Test (6MWT)
- Timed Up and Go Test (TUG)
- Walking Index for Spinal Cord Injury (WISCI) and WISCI II
| 8 weeks | 03 March 2022 | 05 February 2024 | 1 | |
| NCT06214208 | Influence of Spinal Stimulation Frequency on Spasticity, Motor Control, and Pain After Spinal Cord Injury | Shepherd Center, Atlanta GA | | - Age ≥ 16 yrs
- Level C1-T12
AIS A, B, C, D- ≥ 3 months
- NOT have had heart issues
- NOT have implanted stimulators
| Recruiting | 36 | NA | Technology | Spasticity | - Pendulum Test (Wartenberg)
- Penn Spasm Frequency Scale (PSFS)
- Surface Electromyography (sEMG)
| each session | 19 February 2024 | 19 January 2024 | 1 | |
